Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI

Cyclophosphamide combined with total body irradiation (Cy/TBI) or busulfan (BuCy) are the most widely used myeloablative conditioning regimens for allotransplants. Recent data regarding their comparative effectiveness are lacking. We analyzed data from the Center for International Blood and Marrow T...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Copelan, Edward A., Hamilton, Betty K., Avalos, Belinda, Ahn, Kwang Woo, Bolwell, Brian J., Zhu, Xiaochun, Aljurf, Mahmoud, van Besien, Koen, Bredeson, Christopher, Cahn, Jean-Yves, Costa, Luciano J., de Lima, Marcos, Gale, Robert Peter, Hale, Gregory A., Halter, Joerg, Hamadani, Mehdi, Inamoto, Yoshihiro, Kamble, Rammurti T., Litzow, Mark R., Loren, Alison W., Marks, David I., Olavarria, Eduardo, Roy, Vivek, Sabloff, Mitchell, Savani, Bipin N., Seftel, Matthew, Schouten, Harry C., Ustun, Celalettin, Waller, Edmund K., Weisdorf, Daniel J., Wirk, Baldeep, Horowitz, Mary M., Arora, Mukta, Szer, Jeff, Cortes, Jorge, Kalaycio, Matt E., Maziarz, Richard T., Saber, Wael
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2013
Assuntos:
Plenary Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854108/
https://ncbi.nlm.nih.gov/pubmed/24065243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-07-514448
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados